查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1985490

呼吸系统诊断市场：2026-2032年全球市场预测（按诊断测试、患者群体、提供的服务和最终用户划分）

Respiratory Diagnostics Market by Diagnostic Tests, Patient Demographics, Offerings, End Users - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 188 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，呼吸系统诊断市场价值将达到 72.6 亿美元，到 2026 年将成长至 78.6 亿美元，到 2032 年将达到 131.6 亿美元，复合年增长率为 8.86%。

主要市场统计数据
基准年 2025 72.6亿美元
预计年份：2026年 78.6亿美元
预测年份 2032 131.6亿美元
复合年增长率 (%) 8.86%

在新兴技术和监管趋势的驱动下，应对复杂的呼吸系统诊断环境。

呼吸系统诊断领域正经历前所未有的快速变革，这既得益于技术创新，也得益于全​​球健康问题的迫切性。慢性呼吸系统疾病盛行率的上升和患者健康意识的增强，正推动该行业进入一个充满活力的演进阶段。先进的分析工具、照护现场设备和数位健康平台的融合，正在建立更精准、更快捷、更容易取得的诊断路径。此外，关键市场不断变化的监管要求也带来了新的合规挑战，要求整个价值链采取适应性策略。

探索关键的技术和营运变革，以重塑后疫情时代的呼吸系统诊断生态系统。

过去几年，呼吸系统诊断领域因数位医疗的突破性进展和人工智慧的融合而发生了翻天覆地的变化。机器学习演算法如今能够支援高解析度影像的分析，使临床医生能够更精准地检测早期异常。同时，基于云端的分析平台实现了跨多个管道患者数据的无缝整合，从而提供更全面的疾病进展洞察。这些变革不仅缩短了诊断时间，也降低了整体营运成本。

分析 2025 年美国关税对供应链、成本结构和市场适应的综合影响。

美国2025年实施的关税调整对全球呼吸系统诊断供应链产生了重大影响。进口零件的关税上调，迫使设备製造商重新评估其筹资策略和合作伙伴网路。结果，生产成本大幅上升，尤其是高精度成像系统和先进分子检测套组的生产成本。为因应这项挑战，一些主要企业采取了近岸外包策略，将组装迁至更靠近终端市场的位置，以减轻关税的影响并确保供应的连续性。

从测试方法、人口统计群体、解决方案和最终用户应用等不同角度分析市场观点。

对诊断检测技术的详细分析表明，动脉血气分析和血液常规检查等血液检测仍然是评估呼吸功能和识别全身性发炎的基本工具。包括胸部X光片、 电脑断层扫描和MRI扫描在内的影像学平台仍然是可视化结构异常的关键方法。同时，肺功能检查，例如肺活量测定、弥散能力测量和肺容量评估，对于追踪疾病进展和指导治疗性介入至关重要。 PCR检测、抗原检测和生物标记分析等先进的分子检测进一步提高了诊断准确性，而脉搏血氧计和痰液分析通讯协定则可在临床和家庭环境中进行持续监测。

分析美洲、欧洲、中东和非洲以及亚太地区呼吸诊断市场的区域成长要素和市场细微差别。

呼吸系统诊断领域的区域发展趋势因医疗基础设施成熟度、法规环境和经济因素的不同而呈现出明显的差异。在美洲，先进的临床网络和完善的保险报销体系推动了高端影像系统和分子诊断技术的快速普及。同时，研究经费和公共卫生倡议也进一步增强了市场发展动能。欧洲、中东和非洲地区的市场环境则更为复杂：西欧市场强调技术进步和严格的监管合规，而中东和非洲国家则致力于透过官民合作关係和有针对性的疾病筛检计画来提升自身能力。

揭示引领呼吸系统诊断技术发展的主要企业所采用的竞争和创新策略。

呼吸系统诊断领域的主要企业正着力于几项关键策略，以保持其竞争优势。成像系统製造商与软体分析供应商之间正在建立策略合作伙伴关係，将硬体创新与先进的数据分析演算法相结合。这种合作模式正在加速整合诊断平台的部署，从而实现无缝资料交换和远端存取。同时，大型诊断集团收购专注于特定领域的分子检测开发公司，正在增强其检测产品组合，扩大疾病检测范围，并促进个人化治疗方案的发展。

呼吸系统诊断产业在加强创新、协作和业务永续营运方面面临的富有洞察力的策略挑战。

为了最大限度地掌握市场机会，产业领导企业应优先投资于可互通的数位平台，这些平台能够整合各种诊断资料流并实现即时决策支援。透过与软体开发商和学术机构建立协作生态系统，各组织可以共同开发先进的分析解决方案，以预测不断变化的临床需求。同时，透过双重采购和近岸外包实现供应链多元化，可以减轻关税相关的干扰，并确保设备供应稳定。

阐明一个严格的多阶段研究框架，该框架整合了主要检验和次要分析，以实现可靠的呼吸系统诊断智慧。

本研究采用严谨的多阶段方法，确保最高的准确性和可靠性。主要资料收集包括对关键意见领袖（KOL）的全面访谈，这些意见领袖包括呼吸科医生、实验室管理人员和监管专家，旨在获取有关新兴趋势、临床工作流程和采购因素的第一手资料。除这些定性见解外，本研究还对公开文件、技术白皮书和监管资料库进行了详细的审查，为二手资料的收集奠定了坚实的基础。

整合关键发现和未来展望，以指导呼吸系统诊断领域的策略发展和产业前景。

综合本摘要中的关键见解，我们可以发现呼吸系统诊断领域正步入一个以数位整合、策略性供应链重组和协同创新为特征的新时代。先进影像平台与分子检测技术的融合，正推动我们对呼吸系统疾病有更深入的理解。同时，监理改革和关税政策也凸显了营运弹性和积极主动的相关人员参与的重要性。

目录

第一章：序言

第二章：调查方法

  • 调查设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查的前提
  • 研究限制

第三章执行摘要

  • 首席主管观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 市场进入策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会映射
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章 呼吸系统诊断市场（依诊断测试分类）

  • 验血
    • 动脉血气分析
    • 血液常规检查
  • 影像检查
    • 胸部X光片
    • 电脑断层扫描
    • 核磁共振扫描
  • 肺功能测试
    • 扩散能力测试
    • 肺容量测试
    • 肺功能测定
  • 分子检测
    • 抗原检测
    • 生物标记检测
    • PCR检测
  • 脉搏血氧计
  • 痰液检查

第九章 按患者细分分類的呼吸系统诊断市场

  • 成人版
  • 老年人
  • 儿童

第十章 呼吸系统诊断市场：依产品/服务分类

  • 装置
    • 体容积测量装置
    • 医学影像系统
    • 气体分析仪
    • 肺活量测定係统
  • 服务
  • 软体
    • 数据分析软体
    • 影像分析软体
    • 肺功能测试（PFT）软体

第十一章 呼吸系统诊断市场：依最终用户划分

  • 学术机构
  • 诊断检查室
  • 医院和诊所
  • 研究机构

第十二章 呼吸系统诊断市场：按地区划分

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十三章 呼吸系统诊断市场：依组别划分

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十四章 呼吸系统诊断市场：依国家划分

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十五章：美国呼吸系统诊断市场

第十六章：中国呼吸系统诊断市场

第十七章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • Abbott Laboratories
  • Adaltis Srl
  • Altona Diagnostics GmbH
  • Becton, Dickinson, and Company
  • Bio-Rad Laboratories, Inc.
  • bioMerieux SA
  • Bioneer Corporation
  • CerTest Biotec SL
  • Daan Gene Co., Ltd.
  • Diatech Pharmacogenetics srl
  • Dragerwerk AG & Co. KGaA
  • F. Hoffmann-La Roche Ltd.
  • GE HealthCare Technologies, Inc.
  • Hologic, Inc.
  • Johnson & Johnson Services, Inc.
  • Koninklijke Philips NV
  • Masimo Corporation
  • Medtronic PLC
  • Merck KGaA
  • ProAxsis by NetScientific PLC
  • Quest Diagnostics Incorporated
  • Quidel Corporation
  • ResMed Corp.
  • Sansure Biotech Inc.
  • SDI Diagnostics, Inc.
  • Seegene Inc.
  • Siemens Healthineers AG
  • Thermo Fisher Scientific Inc.
  • Vitalograph Ltd.
  • ZeptoMetrix LLC
Product Code: MRR-894699F5EBCB

The Respiratory Diagnostics Market was valued at USD 7.26 billion in 2025 and is projected to grow to USD 7.86 billion in 2026, with a CAGR of 8.86%, reaching USD 13.16 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 7.26 billion
Estimated Year [2026] USD 7.86 billion
Forecast Year [2032] USD 13.16 billion
CAGR (%) 8.86%

Navigating the Complex Respiratory Diagnostics Environment with Emerging Technologies and Regulatory Dynamics Steering Future Developments

The respiratory diagnostics landscape has experienced an unprecedented surge in both technological innovation and global health urgency. Driven by rising prevalence of chronic respiratory conditions and heightened patient awareness, the industry has entered a phase of dynamic evolution. Advanced analytical tools, point-of-care devices, and digital health platforms are converging to create more precise, rapid, and accessible diagnostic pathways. Moreover, shifting regulatory requirements across major markets have introduced new compliance challenges, necessitating adaptive strategies across the entire value chain.

Amid these complexities, this report provides a comprehensive exploration of the key market forces influencing respiratory diagnostics. It paints a clear picture of how technological breakthroughs are intersecting with demographic trends, healthcare protocols, and reimbursement frameworks. By establishing a foundational understanding of current drivers and barriers, this introduction sets the stage for deeper analysis. As you navigate this landscape, the insights presented here will illuminate strategic opportunities and potential pitfalls, empowering decision-makers to chart a forward-looking course in an increasingly competitive environment.

Exploring Pivotal Technological and Operational Transformations Reshaping the Respiratory Diagnostics Ecosystem in a Post-Pandemic Era

Over the past several years, respiratory diagnostics has been transformed by breakthroughs in digital health and the integration of artificial intelligence. Machine learning algorithms now support high-resolution imaging interpretation, enabling clinicians to detect early-stage anomalies with greater accuracy. Meanwhile, cloud-based analytics platforms facilitate the seamless aggregation of patient data across multiple touchpoints, offering more holistic insights into disease progression. These shifts have not only accelerated diagnostic timelines but also lowered overall operational costs.

In addition to technological advances, the industry is experiencing a paradigm shift toward decentralized care models. Point-of-care testing solutions are proliferating beyond hospital settings into community clinics and home-based environments. This expansion is accompanied by growing emphasis on patient empowerment and remote monitoring, which together foster proactive disease management. Consequently, manufacturers and service providers are increasingly focusing on modular, portable solutions that can adapt to a range of clinical workflows. These transformative forces are redefining traditional value chains, encouraging stakeholders to adopt agile development and collaborative partnerships.

Analyzing the Compound Effects of United States Tariff Implementations in 2025 on Supply Chains, Cost Structures, and Market Adaptations

The United States' tariff adjustments implemented in 2025 have exerted a considerable influence on the global respiratory diagnostics supply chain. Imported components faced elevated duties, prompting device manufacturers to reassess sourcing strategies and partner networks. As a result, production costs experienced a noticeable escalation, particularly for high-precision imaging systems and advanced molecular assay kits. In response, several key players pursued nearshoring initiatives, relocating assembly lines closer to end markets to mitigate duty impacts and ensure delivery continuity.

Beyond immediate cost implications, these tariff measures have catalyzed broader strategic realignments. Organizations have intensified supplier diversification efforts to reduce dependency on any single geographic region. Concurrently, there has been a surge in investment toward local manufacturing capabilities and quality control infrastructure. These adjustments have not only buffered the effects of trade policy volatility but also fostered resilience in the face of future disruptions. Overall, the cumulative impact of the 2025 tariff regime underscores the critical importance of supply chain agility and strategic foresight in managing regulatory headwinds.

Unpacking Diverse Market Segmentation Perspectives Highlighting Test Modalities, Demographic Cohorts, Solution Offerings, and End-User Applications

An in-depth look at diagnostic test modalities reveals that blood-based assessments such as arterial blood gas analysis and complete blood count remain foundational tools for evaluating respiratory function and identifying systemic inflammation. Imaging platforms spanning chest X-rays, CT scans, and MRI scans continue to serve as critical modalities for visualizing structural abnormalities. At the same time, lung function tests like spirometry, diffusion capacity measurements, and lung volume assessments are essential for tracking disease progression and guiding therapeutic interventions. Advanced molecular tests including PCR assays, antigen detection, and biomarker profiling further enrich diagnostic accuracy, while pulse oximetry and sputum analysis protocols facilitate ongoing monitoring in both clinical and at-home settings.

Patient demographic segmentation highlights how adult populations drive baseline demand, while geriatric cohorts increasingly rely on complex diagnostic combinations to manage age-related pulmonary disorders. Pediatric segments, by contrast, often prioritize minimally invasive and radiation-free techniques, aligning with safety considerations. Examining market offerings underscores that equipment portfolios-ranging from spirometry systems and gas analyzers to body plethysmographs and diagnostic imaging units-form the backbone of capital investment. Complementary services such as calibration, maintenance, and clinical support services reinforce equipment performance. Meanwhile, specialized software solutions offering data analytics, imaging processing, and pulmonary function testing management are gaining traction as indispensable components of integrated diagnostic ecosystems. Finally, end-user analysis indicates that hospitals and clinics represent the primary consumption hubs, followed by diagnostic laboratories, research institutes, and academic institutions, each driving tailored requirements for throughput, data integration, and reporting capabilities.

Dissecting Regional Growth Drivers and Market Nuances across the Americas, Europe Middle East Africa, and Asia-Pacific Respiratory Diagnostics Arenas

Regional dynamics in respiratory diagnostics exhibit clear differentiation driven by healthcare infrastructure maturity, regulatory environments, and economic factors. In the Americas, advanced clinical networks and expansive reimbursement regimes catalyze rapid adoption of high-end imaging systems and molecular diagnostics. Meanwhile, research funding and public health initiatives further strengthen market momentum. The Europe, Middle East, and Africa region presents a multifaceted environment where Western European markets emphasize technological sophistication and stringent regulatory compliance, while Middle Eastern and African nations pursue capacity building through public-private partnerships and targeted disease screening programs.

Asia-Pacific stands out for its diverse market trajectories, as developed economies such as Japan and Australia leverage digital health integration, whereas emerging markets prioritize cost-effective, portable testing solutions to broaden diagnostic reach. Government-led health campaigns and expanding private sector participation are key drivers of growth across the region. Collectively, these regional nuances underscore the importance of tailored go-to-market strategies that align with local regulatory frameworks, reimbursement landscapes, and healthcare delivery models.

Illuminating Competitive Dynamics and Innovation Strategies Employed by Leading Enterprises Shaping the Respiratory Diagnostics Sector's Evolution

Leading organizations within the respiratory diagnostics sphere have converged on a few critical strategies to maintain competitive advantage. Strategic partnerships between imaging system manufacturers and software analytics providers have emerged, combining hardware innovations with advanced data interpretation algorithms. This collaborative approach has accelerated the roll-out of integrated diagnostic platforms capable of seamless data exchange and remote accessibility. Simultaneously, acquisitions of niche molecular assay developers by large diagnostic conglomerates have bolstered assay portfolios, enhancing the scope of disease detection and personalized treatment planning.

New entrants differentiate through agile business models, offering subscription-based or as-a-service equipment deployment to reduce capital expenditure burdens on healthcare providers. Additionally, several companies have established centers of excellence in emerging markets to support localized R&D and regulatory approvals. The focus on continuous product lifecycle management, guided by post-market surveillance and real-world evidence collection, further demonstrates how top-tier players are leveraging data-driven feedback loops to refine their offerings. These collective competitive maneuvers illustrate a sector characterized by rapid consolidation, innovation-driven partnerships, and evolving commercial frameworks.

Delivering Insightful Strategic Imperatives to Enhance Innovation, Collaboration, and Operational Resilience within the Respiratory Diagnostics Industry

To capitalize on market opportunities, industry leaders should prioritize investment in interoperable digital platforms that integrate diverse diagnostic data streams, enabling real-time decision support. By fostering collaborative ecosystems with software developers and academic institutions, organizations can co-create advanced analytics solutions that anticipate evolving clinical needs. Concurrently, diversifying supply chains through dual sourcing and nearshoring can mitigate tariff-related disruptions and ensure consistent device availability.

Moreover, pursuing modular product designs will allow rapid customization for distinct end-user environments, from high-throughput hospital labs to decentralized community clinics. Engaging proactively with regulatory authorities and participating in standards-development consortia will streamline approval pathways and set benchmarks for quality and safety. Finally, embedding sustainability principles into manufacturing and packaging processes will not only address environmental concerns but also resonate with increasingly value-driven procurement practices. Taken together, these recommendations form a cohesive blueprint for sustaining growth and maintaining competitive differentiation within the respiratory diagnostics landscape.

Elucidating a Rigorous Multi-Phased Research Framework Integrating Primary Validation and Secondary Analysis for Robust Respiratory Diagnostics Intelligence

This research employs a meticulous multi-phased approach to ensure the highest level of accuracy and reliability. Primary data collection involved comprehensive interviews with key opinion leaders, including pulmonologists, laboratory directors, and regulatory specialists, to capture firsthand insights on emerging trends, clinical workflows, and procurement drivers. These qualitative findings were supplemented by a detailed review of public filings, technical whitepapers, and regulatory databases, providing a robust secondary data foundation.

Quantitative analysis was conducted through data triangulation methodologies, cross-referencing supply chain metrics, healthcare expenditure reports, and product launch timelines. The resulting data sets underwent rigorous validation, employing statistical techniques to identify outliers and verify consistency. Additionally, a proprietary assessment framework evaluated each technology's maturity, adoption potential, and competitive positioning. This layered research protocol ensures that conclusions are grounded in empirical evidence and reflect the latest evolutions shaping respiratory diagnostics.

Synthesizing Key Discoveries and Future Trajectories to Guide Strategic Progression in Respiratory Diagnostic Endeavors and Sector Perspectives

Drawing together the critical insights outlined throughout this summary, it becomes clear that respiratory diagnostics is entering an era defined by digital integration, strategic supply chain realignment, and collaborative innovation. The interplay between advanced imaging platforms and molecular assays is driving a more nuanced understanding of respiratory pathologies. Simultaneously, regulatory reforms and tariff policies underscore the importance of operational agility and proactive stakeholder engagement.

Looking ahead, organizations that embrace modular, data-driven solutions and cultivate diverse partnerships will be best positioned to navigate market complexities. By applying the strategic imperatives detailed here, decision-makers can capitalize on emerging opportunities, mitigate potential risks, and deliver enhanced patient outcomes. Ultimately, this report offers a roadmap for achieving sustained growth and leadership in a dynamic respiratory diagnostics environment, supporting stakeholders in making informed, future-focused choices.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Respiratory Diagnostics Market, by Diagnostic Tests

  • 8.1. Blood Tests
    • 8.1.1. Arterial Blood Gases
    • 8.1.2. Complete Blood Count
  • 8.2. Imaging Tests
    • 8.2.1. Chest X-Rays
    • 8.2.2. CT Scans
    • 8.2.3. MRI Scans
  • 8.3. Lung Function Tests
    • 8.3.1. Diffusion Capacity Tests
    • 8.3.2. Lung Volume Tests
    • 8.3.3. Spirometry
  • 8.4. Molecular Tests
    • 8.4.1. Antigen Tests
    • 8.4.2. Biomarker Tests
    • 8.4.3. PCR Tests
  • 8.5. Pulse Oximetry
  • 8.6. Sputum Tests

9. Respiratory Diagnostics Market, by Patient Demographics

  • 9.1. Adult
  • 9.2. Geriatric
  • 9.3. Pediatric

10. Respiratory Diagnostics Market, by Offerings

  • 10.1. Equipment
    • 10.1.1. Body Plethysmographs
    • 10.1.2. Diagnostic Imaging Systems
    • 10.1.3. Gas Analysis Devices
    • 10.1.4. Spirometry Systems
  • 10.2. Services
  • 10.3. Software
    • 10.3.1. Data Analytics Software
    • 10.3.2. Imaging Analysis Software
    • 10.3.3. Pulmonary Function Testing (PFT) Software

11. Respiratory Diagnostics Market, by End Users

  • 11.1. Academic Institutions
  • 11.2. Diagnostic Laboratories
  • 11.3. Hospitals & Clinics
  • 11.4. Research Institutes

12. Respiratory Diagnostics Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Respiratory Diagnostics Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Respiratory Diagnostics Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Respiratory Diagnostics Market

16. China Respiratory Diagnostics Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. Abbott Laboratories
  • 17.6. Adaltis S.r.l.
  • 17.7. Altona Diagnostics GmbH
  • 17.8. Becton, Dickinson, and Company
  • 17.9. Bio-Rad Laboratories, Inc.
  • 17.10. bioMerieux S.A.
  • 17.11. Bioneer Corporation
  • 17.12. CerTest Biotec S.L.
  • 17.13. Daan Gene Co., Ltd.
  • 17.14. Diatech Pharmacogenetics srl
  • 17.15. Dragerwerk AG & Co. KGaA
  • 17.16. F. Hoffmann-La Roche Ltd.
  • 17.17. GE HealthCare Technologies, Inc.
  • 17.18. Hologic, Inc.
  • 17.19. Johnson & Johnson Services, Inc.
  • 17.20. Koninklijke Philips N.V.
  • 17.21. Masimo Corporation
  • 17.22. Medtronic PLC
  • 17.23. Merck KGaA
  • 17.24. ProAxsis by NetScientific PLC
  • 17.25. Quest Diagnostics Incorporated
  • 17.26. Quidel Corporation
  • 17.27. ResMed Corp.
  • 17.28. Sansure Biotech Inc.
  • 17.29. SDI Diagnostics, Inc.
  • 17.30. Seegene Inc.
  • 17.31. Siemens Healthineers AG
  • 17.32. Thermo Fisher Scientific Inc.
  • 17.33. Vitalograph Ltd.
  • 17.34. ZeptoMetrix LLC

LIST OF FIGURES

  • FIGURE 1. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL RESPIRATORY DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TESTS, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY OFFERINGS, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY END USERS, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES RESPIRATORY DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA RESPIRATORY DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TESTS, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY BLOOD TESTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY BLOOD TESTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY BLOOD TESTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY BLOOD TESTS, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY ARTERIAL BLOOD GASES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY ARTERIAL BLOOD GASES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY ARTERIAL BLOOD GASES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY COMPLETE BLOOD COUNT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY COMPLETE BLOOD COUNT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY COMPLETE BLOOD COUNT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY CHEST X-RAYS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY CHEST X-RAYS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY CHEST X-RAYS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY CT SCANS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY CT SCANS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY CT SCANS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MRI SCANS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MRI SCANS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MRI SCANS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY LUNG FUNCTION TESTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY LUNG FUNCTION TESTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY LUNG FUNCTION TESTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY LUNG FUNCTION TESTS, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY DIFFUSION CAPACITY TESTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY DIFFUSION CAPACITY TESTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY DIFFUSION CAPACITY TESTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY LUNG VOLUME TESTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY LUNG VOLUME TESTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY LUNG VOLUME TESTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY SPIROMETRY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY SPIROMETRY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY SPIROMETRY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MOLECULAR TESTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MOLECULAR TESTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MOLECULAR TESTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MOLECULAR TESTS, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY ANTIGEN TESTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY ANTIGEN TESTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY ANTIGEN TESTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY BIOMARKER TESTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY BIOMARKER TESTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY BIOMARKER TESTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PCR TESTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PCR TESTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PCR TESTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PULSE OXIMETRY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PULSE OXIMETRY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PULSE OXIMETRY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY SPUTUM TESTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY SPUTUM TESTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY SPUTUM TESTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY ADULT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY ADULT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY ADULT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY GERIATRIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY GERIATRIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY GERIATRIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PEDIATRIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PEDIATRIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY OFFERINGS, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY EQUIPMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY EQUIPMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY EQUIPMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY BODY PLETHYSMOGRAPHS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY BODY PLETHYSMOGRAPHS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY BODY PLETHYSMOGRAPHS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC IMAGING SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC IMAGING SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC IMAGING SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY GAS ANALYSIS DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY GAS ANALYSIS DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY GAS ANALYSIS DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY SPIROMETRY SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY SPIROMETRY SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY SPIROMETRY SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY SERVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY SERVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY SOFTWARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY SOFTWARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY DATA ANALYTICS SOFTWARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY DATA ANALYTICS SOFTWARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY DATA ANALYTICS SOFTWARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING ANALYSIS SOFTWARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING ANALYSIS SOFTWARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING ANALYSIS SOFTWARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PULMONARY FUNCTION TESTING (PFT) SOFTWARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PULMONARY FUNCTION TESTING (PFT) SOFTWARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PULMONARY FUNCTION TESTING (PFT) SOFTWARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY ACADEMIC INSTITUTIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY ACADEMIC INSTITUTIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY ACADEMIC INSTITUTIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY HOSPITALS & CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY HOSPITALS & CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 115. AMERICAS RESPIRATORY DIAGNOSTICS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 116. AMERICAS RESPIRATORY DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TESTS, 2018-2032 (USD MILLION)
  • TABLE 117. AMERICAS RESPIRATORY DIAGNOSTICS MARKET SIZE, BY BLOOD TESTS, 2018-2032 (USD MILLION)
  • TABLE 118. AMERICAS RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2018-2032 (USD MILLION)
  • TABLE 119. AMERICAS RESPIRATORY DIAGNOSTICS MARKET SIZE, BY LUNG FUNCTION TESTS, 2018-2032 (USD MILLION)
  • TABLE 120. AMERICAS RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MOLECULAR TESTS, 2018-2032 (USD MILLION)
  • TABLE 121. AMERICAS RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD MILLION)
  • TABLE 122. AMERICAS RESPIRATORY DIAGNOSTICS MARKET SIZE, BY OFFERINGS, 2018-2032 (USD MILLION)
  • TABLE 123. AMERICAS RESPIRATORY DIAGNOSTICS MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 124. AMERICAS RESPIRATORY DIAGNOSTICS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 125. AMERICAS RESPIRATORY DIAGNOSTICS MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
  • TABLE 126. NORTH AMERICA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 127. NORTH AMERICA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TESTS, 2018-2032 (USD MILLION)
  • TABLE 128. NORTH AMERICA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY BLOOD TESTS, 2018-2032 (USD MILLION)
  • TABLE 129. NORTH AMERICA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2018-2032 (USD MILLION)
  • TABLE 130. NORTH AMERICA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY LUNG FUNCTION TESTS, 2018-2032 (USD MILLION)
  • TABLE 131. NORTH AMERICA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MOLECULAR TESTS, 2018-2032 (USD MILLION)
  • TABLE 132. NORTH AMERICA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD MILLION)
  • TABLE 133. NORTH AMERICA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY OFFERINGS, 2018-2032 (USD MILLION)
  • TABLE 134. NORTH AMERICA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 135. NORTH AMERICA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 136. NORTH AMERICA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
  • TABLE 137. LATIN AMERICA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 138. LATIN AMERICA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TESTS, 2018-2032 (USD MILLION)
  • TABLE 139. LATIN AMERICA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY BLOOD TESTS, 2018-2032 (USD MILLION)
  • TABLE 140. LATIN AMERICA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2018-2032 (USD MILLION)
  • TABLE 141. LATIN AMERICA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY LUNG FUNCTION TESTS, 2018-2032 (USD MILLION)
  • TABLE 142. LATIN AMERICA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MOLECULAR TESTS, 2018-2032 (USD MILLION)
  • TABLE 143. LATIN AMERICA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD MILLION)
  • TABLE 144. LATIN AMERICA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY OFFERINGS, 2018-2032 (USD MILLION)
  • TABLE 145. LATIN AMERICA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 146. LATIN AMERICA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 147. LATIN AMERICA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
  • TABLE 148. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 149. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TESTS, 2018-2032 (USD MILLION)
  • TABLE 150. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY BLOOD TESTS, 2018-2032 (USD MILLION)
  • TABLE 151. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2018-2032 (USD MILLION)
  • TABLE 152. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY LUNG FUNCTION TESTS, 2018-2032 (USD MILLION)
  • TABLE 153. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MOLECULAR TESTS, 2018-2032 (USD MILLION)
  • TABLE 154. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD MILLION)
  • TABLE 155. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY OFFERINGS, 2018-2032 (USD MILLION)
  • TABLE 156. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 157. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 158. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
  • TABLE 159. EUROPE RESPIRATORY DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 160. EUROPE RESPIRATORY DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TESTS, 2018-2032 (USD MILLION)
  • TABLE 161. EUROPE RESPIRATORY DIAGNOSTICS MARKET SIZE, BY BLOOD TESTS, 2018-2032 (USD MILLION)
  • TABLE 162. EUROPE RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2018-2032 (USD MILLION)
  • TABLE 163. EUROPE RESPIRATORY DIAGNOSTICS MARKET SIZE, BY LUNG FUNCTION TESTS, 2018-2032 (USD MILLION)
  • TABLE 164. EUROPE RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MOLECULAR TESTS, 2018-2032 (USD MILLION)
  • TABLE 165. EUROPE RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD MILLION)
  • TABLE 166. EUROPE RESPIRATORY DIAGNOSTICS MARKET SIZE, BY OFFERINGS, 2018-2032 (USD MILLION)
  • TABLE 167. EUROPE RESPIRATORY DIAGNOSTICS MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 168. EUROPE RESPIRATORY DIAGNOSTICS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 169. EUROPE RESPIRATORY DIAGNOSTICS MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
  • TABLE 170. MIDDLE EAST RESPIRATORY DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 171. MIDDLE EAST RESPIRATORY DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TESTS, 2018-2032 (USD MILLION)
  • TABLE 172. MIDDLE EAST RESPIRATORY DIAGNOSTICS MARKET SIZE, BY BLOOD TESTS, 2018-2032 (USD MILLION)
  • TABLE 173. MIDDLE EAST RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2018-2032 (USD MILLION)
  • TABLE 174. MIDDLE EAST RESPIRATORY DIAGNOSTICS MARKET SIZE, BY LUNG FUNCTION TESTS, 2018-2032 (USD MILLION)
  • TABLE 175. MIDDLE EAST RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MOLECULAR TESTS, 2018-2032 (USD MILLION)
  • TABLE 176. MIDDLE EAST RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD MILLION)
  • TABLE 177. MIDDLE EAST RESPIRATORY DIAGNOSTICS MARKET SIZE, BY OFFERINGS, 2018-2032 (USD MILLION)
  • TABLE 178. MIDDLE EAST RESPIRATORY DIAGNOSTICS MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 179. MIDDLE EAST RESPIRATORY DIAGNOSTICS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 180. MIDDLE EAST RESPIRATORY DIAGNOSTICS MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
  • TABLE 181. AFRICA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 182. AFRICA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TESTS, 2018-2032 (USD MILLION)
  • TABLE 183. AFRICA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY BLOOD TESTS, 2018-2032 (USD MILLION)
  • TABLE 184. AFRICA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2018-2032 (USD MILLION)
  • TABLE 185. AFRICA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY LUNG FUNCTION TESTS, 2018-2032 (USD MILLION)
  • TABLE 186. AFRICA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MOLECULAR TESTS, 2018-2032 (USD MILLION)
  • TABLE 187. AFRICA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD MILLION)
  • TABLE 188. AFRICA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY OFFERINGS, 2018-2032 (USD MILLION)
  • TABLE 189. AFRICA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 190. AFRICA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 191. AFRICA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
  • TABLE 192. ASIA-PACIFIC RESPIRATORY DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 193. ASIA-PACIFIC RESPIRATORY DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TESTS, 2018-2032 (USD MILLION)
  • TABLE 194. ASIA-PACIFIC RESPIRATORY DIAGNOSTICS MARKET SIZE, BY BLOOD TESTS, 2018-2032 (USD MILLION)
  • TABLE 195. ASIA-PACIFIC RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2018-2032 (USD MILLION)
  • TABLE 196. ASIA-PACIFIC RESPIRATORY DIAGNOSTICS MARKET SIZE, BY LUNG FUNCTION TESTS, 2018-2032 (USD MILLION)
  • TABLE 197. ASIA-PACIFIC RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MOLECULAR TESTS, 2018-2032 (USD MILLION)
  • TABLE 198. ASIA-PACIFIC RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD MILLION)
  • TABLE 199. ASIA-PACIFIC RESPIRATORY DIAGNOSTICS MARKET SIZE, BY OFFERINGS, 2018-2032 (USD MILLION)
  • TABLE 200. ASIA-PACIFIC RESPIRATORY DIAGNOSTICS MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 201. ASIA-PACIFIC RESPIRATORY DIAGNOSTICS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 202. ASIA-PACIFIC RESPIRATORY DIAGNOSTICS MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
  • TABLE 203. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 204. ASEAN RESPIRATORY DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 205. ASEAN RESPIRATORY DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TESTS, 2018-2032 (USD MILLION)
  • TABLE 206. ASEAN RESPIRATORY DIAGNOSTICS MARKET SIZE, BY BLOOD TESTS, 2018-2032 (USD MILLION)
  • TABLE 207. ASEAN RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2018-2032 (USD MILLION)
  • TABLE 208. ASEAN RESPIRATORY DIAGNOSTICS MARKET SIZE, BY LUNG FUNCTION TESTS, 2018-2032 (USD MILLION)
  • TABLE 209. ASEAN RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MOLECULAR TESTS, 2018-2032 (USD MILLION)
  • TABLE 210. ASEAN RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD MILLION)
  • TABLE 211. ASEAN RESPIRATORY DIAGNOSTICS MARKET SIZE, BY OFFERINGS, 2018-2032 (USD MILLION)
  • TABLE 212. ASEAN RESPIRATORY DIAGNOSTICS MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 213. ASEAN RESPIRATORY DIAGNOSTICS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 214. ASEAN RESPIRATORY DIAGNOSTICS MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
  • TABLE 215. GCC RESPIRATORY DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 216. GCC RESPIRATORY DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TESTS, 2018-2032 (USD MILLION)
  • TABLE 217. GCC RESPIRATORY DIAGNOSTICS MARKET SIZE, BY BLOOD TESTS, 2018-2032 (USD MILLION)
  • TABLE 218. GCC RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2018-2032 (USD MILLION)
  • TABLE 219. GCC RESPIRATORY DIAGNOSTICS MARKET SIZE, BY LUNG FUNCTION TESTS, 2018-2032 (USD MILLION)
  • TABLE 220. GCC RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MOLECULAR TESTS, 2018-2032 (USD MILLION)
  • TABLE 221. GCC RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD MILLION)
  • TABLE 222. GCC RESPIRATORY DIAGNOSTICS MARKET SIZE, BY OFFERINGS, 2018-2032 (USD MILLION)
  • TABLE 223. GCC RESPIRATORY DIAGNOSTICS MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 224. GCC RESPIRATORY DIAGNOSTICS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 225. GCC RESPIRATORY DIAGNOSTICS MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
  • TABLE 226. EUROPEAN UNION RESPIRATORY DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 227. EUROPEAN UNION RESPIRATORY DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TESTS, 2018-2032 (USD MILLION)
  • TABLE 228. EUROPEAN UNION RESPIRATORY DIAGNOSTICS MARKET SIZE, BY BLOOD TESTS, 2018-2032 (USD MILLION)
  • TABLE 229. EUROPEAN UNION RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2018-2032 (USD MILLION)
  • TABLE 230. EUROPEAN UNION RESPIRATORY DIAGNOSTICS MARKET SIZE, BY LUNG FUNCTION TESTS, 2018-2032 (USD MILLION)
  • TABLE 231. EUROPEAN UNION RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MOLECULAR TESTS, 2018-2032 (USD MILLION)
  • TABLE 232. EUROPEAN UNION RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD MILLION)
  • TABLE 233. EUROPEAN UNION RESPIRATORY DIAGNOSTICS MARKET SIZE, BY OFFERINGS, 2018-2032 (USD MILLION)
  • TABLE 234. EUROPEAN UNION RESPIRATORY DIAGNOSTICS MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 235. EUROPEAN UNION RESPIRATORY DIAGNOSTICS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 236. EUROPEAN UNION RESPIRATORY DIAGNOSTICS MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
  • TABLE 237. BRICS RESPIRATORY DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 238. BRICS RESPIRATORY DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TESTS, 2018-2032 (USD MILLION)
  • TABLE 239. BRICS RESPIRATORY DIAGNOSTICS MARKET SIZE, BY BLOOD TESTS, 2018-2032 (USD MILLION)
  • TABLE 240. BRICS RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2018-2032 (USD MILLION)
  • TABLE 241. BRICS RESPIRATORY DIAGNOSTICS MARKET SIZE, BY LUNG FUNCTION TESTS, 2018-2032 (USD MILLION)
  • TABLE 242. BRICS RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MOLECULAR TESTS, 2018-2032 (USD MILLION)
  • TABLE 243. BRICS RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD MILLION)
  • TABLE 244. BRICS RESPIRATORY DIAGNOSTICS MARKET SIZE, BY OFFERINGS, 2018-2032 (USD MILLION)
  • TABLE 245. BRICS RESPIRATORY DIAGNOSTICS MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 246. BRICS RESPIRATORY DIAGNOSTICS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 247. BRICS RESPIRATORY DIAGNOSTICS MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
  • TABLE 248. G7 RESPIRATORY DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 249. G7 RESPIRATORY DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TESTS, 2018-2032 (USD MILLION)
  • TABLE 250. G7 RESPIRATORY DIAGNOSTICS MARKET SIZE, BY BLOOD TESTS, 2018-2032 (USD MILLION)
  • TABLE 251. G7 RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2018-2032 (USD MILLION)
  • TABLE 252. G7 RESPIRATORY DIAGNOSTICS MARKET SIZE, BY LUNG FUNCTION TESTS, 2018-2032 (USD MILLION)
  • TABLE 253. G7 RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MOLECULAR TESTS, 2018-2032 (USD MILLION)
  • TABLE 254. G7 RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD MILLION)
  • TABLE 255. G7 RESPIRATORY DIAGNOSTICS MARKET SIZE, BY OFFERINGS, 2018-2032 (USD MILLION)
  • TABLE 256. G7 RESPIRATORY DIAGNOSTICS MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 257. G7 RESPIRATORY DIAGNOSTICS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 258. G7 RESPIRATORY DIAGNOSTICS MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
  • TABLE 259. NATO RESPIRATORY DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 260. NATO RESPIRATORY DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TESTS, 2018-2032 (USD MILLION)
  • TABLE 261. NATO RESPIRATORY DIAGNOSTICS MARKET SIZE, BY BLOOD TESTS, 2018-2032 (USD MILLION)
  • TABLE 262. NATO RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2018-2032 (USD MILLION)
  • TABLE 263. NATO RESPIRATORY DIAGNOSTICS MARKET SIZE, BY LUNG FUNCTION TESTS, 2018-2032 (USD MILLION)
  • TABLE 264. NATO RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MOLECULAR TESTS, 2018-2032 (USD MILLION)
  • TABLE 265. NATO RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD MILLION)
  • TABLE 266. NATO RESPIRATORY DIAGNOSTICS MARKET SIZE, BY OFFERINGS, 2018-2032 (USD MILLION)
  • TABLE 267. NATO RESPIRATORY DIAGNOSTICS MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 268. NATO RESPIRATORY DIAGNOSTICS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 269. NATO RESPIRATORY DIAGNOSTICS MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
  • TABLE 270. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 271. UNITED STATES RESPIRATORY DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 272. UNITED STATES RESPIRATORY DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TESTS, 2018-2032 (USD MILLION)
  • TABLE 273. UNITED STATES RESPIRATORY DIAGNOSTICS MARKET SIZE, BY BLOOD TESTS, 2018-2032 (USD MILLION)
  • TABLE 274. UNITED STATES RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2018-2032 (USD MILLION)
  • TABLE 275. UNITED STATES RESPIRATORY DIAGNOSTICS MARKET SIZE, BY LUNG FUNCTION TESTS, 2018-2032 (USD MILLION)
  • TABLE 276. UNITED STATES RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MOLECULAR TESTS, 2018-2032 (USD MILLION)
  • TABLE 277. UNITED STATES RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD MILLION)
  • TABLE 278. UNITED STATES RESPIRATORY DIAGNOSTICS MARKET SIZE, BY OFFERINGS, 2018-2032 (USD MILLION)
  • TABLE 279. UNITED STATES RESPIRATORY DIAGNOSTICS MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 280. UNITED STATES RESPIRATORY DIAGNOSTICS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 281. UNITED STATES RESPIRATORY DIAGNOSTICS MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
  • TABLE 282. CHINA RESPIRATORY DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 283. CHINA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TESTS, 2018-2032 (USD MILLION)
  • TABLE 284. CHINA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY BLOOD TESTS, 2018-2032 (USD MILLION)
  • TABLE 285. CHINA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2018-2032 (USD MILLION)
  • TABLE 286. CHINA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY LUNG FUNCTION TESTS, 2018-2032 (USD MILLION)
  • TABLE 287. CHINA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MOLECULAR TESTS, 2018-2032 (USD MILLION)
  • TABLE 288. CHINA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD MILLION)
  • TABLE 289. CHINA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY OFFERINGS, 2018-2032 (USD MILLION)
  • TABLE 290. CHINA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 291. CHINA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 292. CHINA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)